Sandra J Meischen

Title: The Innovative Contributions of Sandra J. Meischen

Introduction

Sandra J. Meischen is a notable inventor based in Charleston, SC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 4 patents to her name, her work has had a profound impact on cancer treatment.

Latest Patents

One of her latest patents involves the compound N-Phosphonacetyl-L-aspartato(1,2-diaminocyclohexane)platinum(II). This compound has demonstrated antitumor activity against various types of tumors, including murine leukemia L1210, B-16, and Colon 38 tumors, as well as Ehrlich ascites tumor. The effective dosages range from 5-60 mg/kg of body weight and can be potentiated when combined with cyclophosphamide and hydroxyurea. The compound can also be used in a binary treatment with cisplatin, with a preferred ratio of about 10:1.

Career Highlights

Throughout her career, Sandra has worked with the United States of America as represented by the Department of Health and the Government of the United States of America. Her innovative research has contributed to advancements in cancer therapies and has been recognized within the scientific community.

Collaborations

Some of her notable coworkers include Glen R. Gale and Marion B. Naff, who have collaborated with her on various projects.

Conclusion

Sandra J. Meischen's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her role as an influential inventor. Her innovative work continues to pave the way for advancements in medical science.